#United States #DJS Law Group #Eastchester #MoonLake #MLTX

MoonLake Immunotherapeutics Faces Class Action Lawsuit

Investors in MoonLake Immunotherapeutics (NASDAQ: MLTX) have been alerted to a class action lawsuit filed by the DJS Law Group, focusing on alleged violations of the Securities Exchange Act of 1934. This lawsuit draws attention to significant claims that the company misrepresented its drug, sonelokimab (SLK), comparing it favorably to competitive therapies despite lacking substantial evidence of superiority.

Summary of Allegations

The lawsuit specifically addresses statements made by MoonLake during a critical period from March 10, 2024, to September 29, 2025. According to the complaint, the company indicated that SLK would outperform other treatments, which analysts later challenged as unfounded claims. Once the Phase 3 trial results were released, they were markedly disappointing, leading to severe market reactions and raising doubts about the integrity of the company's prior assertions.

Impact on Shareholders

As a result of these incidents, shareholders who purchased MLTX shares during the defined class period are encouraged to reach out to DJS Law Group. Being appointed as a lead plaintiff is not a prerequisite for potential recovery, making participation accessible for all affected investors. Those interested can register to receive updates on the case's developments, ensuring they're informed throughout the legal process at no cost.

The Role of DJS Law Group

DJS Law Group has established a reputation for advocating on behalf of investors, emphasizing diligent representation in securities class actions. Their approach combines relentless advocacy with strategic guidance, fostering an environment where investor rights are prioritized. They have represented various clients, including some of the world's largest hedge funds and asset managers—a testament to their expertise and trust.

Next Steps for Affected Investors

Shareholders with claims are encouraged to connect with DJS Law Group by December 15, 2025, to discuss their rights and options available for recovery. Engaging with legal professionals is crucial, especially amidst potential volatility in the market tied to this lawsuit.

Contact Information

Those seeking assistance can contact David J. Schwartz at DJS Law Group, located at 274 White Plains Road, Suite 1 Eastchester, NY 10709. Investors can reach out via phone at 914-206-9742 or email at [email protected].

In light of these events, affected shareholders are advised to stay proactive and informed. The outcome of this case may not only impact their accounts but also highlight regulatory adherence in the biopharmaceutical sector. Updates will continue to unfold as the case progresses, and involvement in shareholder recovery initiatives remains paramount for those impacted by MoonLake's alleged misrepresentation.